Nexien BioPharma, Inc. (NXEN)

Market Cap	7.08K
Revenue (ttm)	n/a
Net Income (ttm)	-188.08K
Shares Out	70.77M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	34,972
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0150
Beta	-1.06
RSI	39.26
Earnings Date	Nov 19, 2025

About Nexien BioPharma

Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Richard Greenberg
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: NXEN